CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The EPI-CART project aims to enhance CAR T cell therapy for blood cancers by focusing on epigenetic regulation. It investigates patient-specific responses and develops a platform to engineer improved CAR T cells for challenging cancers, utilizing advanced profiling techniques and in vivo models.
The dramatic efficacy of CAR T cell therapy in certain hematopoietic malignancies provides clinical validation of a groundbreaking paradigm:
Human cells can be engineered into purpose-built therapeutic agents by genetically introducing artificial regulatory programs.
The EPI-CART project will focus on epigenetic regulation in CAR T cell therapy – an important but underappreciated aspect of all cell-based therapies.We will investigate the regulatory dynamics during CAR T cell therapy in unprecede…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
